Abstract Objective To explore the molecular characteristics of Staphylococcus aureus (S. aureus) in children, and to compare the molecular characteristics of different types of strains (infection and colonization strains) so as to reveal pathogenic molecular markers of S. aureus. Methods A cross-sectional study design was used to conduct nasopharyngeal swab sampling from healthy children in the community and clinical samples from infected children in the hospital. Whole genome sequencing was used to detect antibiotic resistance genes and virulence genes. A random forest method to used to screen pathogenic markers. Results A total of 512 S. aureus strains were detected, including 272 infection strains and 240 colonization strains. For virulence genes, the carrying rates of enterotoxin genes (seb and sep), extracellular enzyme coding genes (splA, splB, splE and edinC), leukocytotoxin genes (lukD, lukE, lukF-PV and lukS-PV) and epidermal exfoliating genes (eta and etb) in infection strains were higher than those in colonization strains. But the carrying rates of enterotoxin genes (sec, sec3, seg, seh, sei, sel, sem, sen, seo and seu) were lower in infection strains than in colonization strains (P<0.05). For antibiotic resistance genes, the carrying rates of lnuA, lnuG, aadD, tetK and dfrG were significantly higher in infection strains than in colonization strains (P<0.05). The accuracy of cross-validation of the random forest model for screening pathogenic markers of S. aureus before and after screening was 69% and 68%, respectively, and the area under the curve was 0.75 and 0.70, respectively. The random forest model finally screened out 16 pathogenic markers (sem, etb, splE, sep, ser, mecA, lnuA, sea, blaZ, cat(pC233), blaTEm-1A, aph(3')-III, ermB, ermA, ant(9)-Ia and ant(6)-Ia). The top five variables in the variable importance ranking were sem (OR=0.40), etb (OR=3.95), splE (OR=1.68), sep (OR=3.97), and ser (OR=1.68). Conclusions The random forest model can screen out pathogenic markers of S. aureus and exhibits a superior predictive performance, providing genetic evidence for tracing highly pathogenic S. aureus and conducting precise targeted interventions.
Corresponding Authors:
Ye X-H,E-mail：smalltomato@163.com。
E-mail: smalltomato@163.com
Cite this article:
CHEN Jian-Yu,WANG Xu-Lin,LI Wen-Yu et al. Screening of pathogenic molecular markers of Staphylococcus aureus in children based on whole genome sequencing technology[J]. CJCP, 2023, 25(11): 1161-1169.
CHEN Jian-Yu,WANG Xu-Lin,LI Wen-Yu et al. Screening of pathogenic molecular markers of Staphylococcus aureus in children based on whole genome sequencing technology[J]. CJCP, 2023, 25(11): 1161-1169.
Hamdy RF, Dona D, Jacobs MB, et al. Risk factors for complications in children with Staphylococcus aureus bacteremia[J]. J Pediatr, 2019, 208: 214-220.e2. PMID: 30879729. DOI: 10.1016/j.jpeds.2018.12.002.
Shettigar K, Murali TS. Virulence factors and clonal diversity of Staphylococcus aureus in colonization and wound infection with emphasis on diabetic foot infection[J]. Eur J Clin Microbiol Infect Dis, 2020, 39(12): 2235-2246. PMID: 32683595. PMCID: PMC7669779. DOI: 10.1007/s10096-020-03984-8.
Prjibelski A, Antipov D, Meleshko D, et al. Using SPAdes de novo assembler[J]. Curr Protoc Bioinformatics, 2020, 70(1): e102. PMID: 32559359. DOI: 10.1002/cpbi.102.
Etter D, Schelin J, Schuppler M, et al. Staphylococcal enterotoxin C: an update on SEC variants, their structure and properties, and their role in foodborne intoxications[J]. Toxins (Basel), 2020, 12(9): 584. PMID: 32927913. PMCID: PMC7551944. DOI: 10.3390/toxins12090584.
Lo WT, Wang SR, Tseng MH, et al. Comparative molecular analysis of meticillin-resistant Staphylococcus aureus isolates from children with atopic dermatitis and healthy subjects in Taiwan[J]. Br J Dermatol, 2010, 162(5): 1110-1116. PMID: 20132206. DOI: 10.1111/j.1365-2133.2010.09679.x.
Pérez-Montarelo D, Viedma E, Larrosa N, et al. Molecular epidemiology of Staphylococcus aureus bacteremia: association of molecular factors with the source of infection[J]. Front Microbiol, 2018, 9: 2210. PMID: 30319561. PMCID: PMC6167439. DOI: 10.3389/fmicb.2018.02210.
Lange J, Heidenreich K, Higelin K, et al. Staphylococcus aureus pathogenicity in cystic fibrosis patients: results from an observational prospective multicenter study concerning virulence genes, phylogeny, and gene plasticity[J]. Toxins (Basel), 2020, 12(5): 279. PMID: 32357453. PMCID: PMC7290773. DOI: 10.3390/toxins12050279.
